ABG
Ally Bridge Group Portfolio holdings
AUM
$114M
This Quarter Return
-9.85%
1 Year Return
+41.64%
3 Year Return
+246.39%
5 Year Return
–
10 Year Return
–
AUM
$110M
AUM Growth
+$110M
(-19%)
Cap. Flow
-$778K
Cap. Flow
% of AUM
-0.71%
Top 10 Holdings %
Top 10 Hldgs %
66.13%
Holding
26
New
5
Increased
2
Reduced
2
Closed
4
Top Buys
| 1 |
argenx
ARGX
|
$14.9M |
| 2 |
MDVL
MedAvail Holdings, Inc. Common Stock
MDVL
|
$4.55M |
| 3 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$4.37M |
| 4 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$3.22M |
| 5 |
Relmada Therapeutics
RLMD
|
$3.04M |
Top Sells
| 1 |
Lantheus
LNTH
|
$11.2M |
| 2 |
Arvinas
ARVN
|
$10.1M |
| 3 |
Intellia Therapeutics
NTLA
|
$4.36M |
| 4 |
Cogent Biosciences
COGT
|
$4.08M |
| 5 |
Sight Sciences
SGHT
|
$3.64M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Arvinas
ARVN
$580M
| – | – |
-150,000
| Closed | -$10.1M |
|